Jf. Sunahara et al., POSSIBLE ERYTHROMELALGIA-LIKE SYNDROME-ASSOCIATED WITH NIFEDIPINE IN A PATIENT WITH RAYNAUDS-PHENOMENON, The Annals of pharmacotherapy, 30(5), 1996, pp. 484-486
OBJECTIVE: To describe a patient who was diagnosed with Raynaud's phen
omenon, was prescribed immediate-release nifedipine, and developed a p
ossible erythromelalgia-like syndrome. CASE SUMMARY: A 24-year-old whi
te woman with a history of esophageal spasms and Raynaud's phenomenon
was prescribed nifedipine 10 mg po qid. Approximately 1 hour after the
patient had taken the fourth dose of nifedipine, she experienced acut
e erythema and a burning sensation in her feet and lower limbs, light-
headedness, and palpitations. Because of a reportedly abnormally low b
lood pressure, the patient took diphenhydramine 50 mg po and proceeded
to the clinic. On arrival, abnormal vital signs were BP 140/48 mm Hg
and HR 130 beats/min. Without any other medical intervention, approxim
ately 30 minutes later her blood pressure and heart rate had returned
to baseline at 122/60 mm Hg and 96 beats/min, respectively. The nifedi
pine was permanently discontinued and the patient's symptoms completel
y resolved over 24 hours. DISCUSSION: The characteristic symptoms of e
rythromelalgia include burning pain, increased skin temperature, and e
rythema of the extremities, usually to the feet, lower legs, and, less
often, the hands. Erythromelalgia-like syndromes secondary to the adm
inistration of many medications have been reported. Several nifedipine
-related reports describe an erythromelalgia-like syndrome similar to
our reported case. CONCLUSIONS: Because the patient was not taking any
other medications and the symptoms started with the administration of
nifedipine and were relieved after its discontinuation, nifedipine wa
s thought to be the cause of the erythromelalgia-like syndrome.